Preview

Пульмонология

Расширенный поиск

Аспирационная пневмония: современные подходы к диагностике и терапии

https://doi.org/10.18093/0869-0189-2009-2-5-19

Полный текст:

Об авторе

С.Н. Авдеев
ФГУ НИИ пульмонологии ФМБА России
Россия


Список литературы

1. Marik P.E. Aspiration pneumonitis and aspiration pneumonia. N. Engl. J. Med. 2001; 344: 665-671.

2. The committee for The Japanese Respiratory Society guidelines in management of respiratory infections. Aspiration pneumonia. Respirology 2004; 9: S35-S37.

3. Mandell L.A., Wunderink R.G., Anzueto A. et al. Infectious Diseases Society of America / American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 (suppl. 2): S27-S72.

4. American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 388-416.

5. Авдеев С.Н. Аспирационная пневмония. Рус. мед. журн. 2001; 9: 934-939.

6. Bartlett J.G., Gorbach S.L. The triple threat of aspiration pneumonia. Chest 1975; 68: 560-566.

7. Bartlett J.G. Aspiration pneumonia in adults. UpToDate. Last literature review for version 16.1: 2008.

8. Чучалин А.Г., Синопальников А.И., Страчунский Л.С. и др. Внутрибольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. Клин. микробиол. антимикроб. химиотер. 2006; 8: 54-86.

9. Jurado R.L., Franco-Paredes C. Aspiration pneumonia: a misnomer. Clin. Infect. Dis. 2001; 33: 1611-1612.

10. Hill M.K., Sanders C.V. Anaerobic disease of the lung. Infect. Dis. Clin. North Am. 1991; 5: 53-66.

11. Bartlett J.G., Gorbach S.L., Finegold S.M. The bacteriology of aspiration pneumonia. Am. J. Med. 1974; 56: 202-207.

12. Bartlett J.G. Anaerobic bacterial pneumonitis. Am. Rev. Respir. Dis. 1979; 119: 19-23.

13. Huxley EJ, Viroslav J, Gray WR, et al. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978; 64: 564- 568.

14. Kikuchi R., Watanabe N., Konno T. et al. High incidence of silent aspiration in elderly patients with community acquired pneumonia. Am. J. Respir. Crit. Care Med. 1994; 150: 251-253.

15. Gleeson K Eggli D.F., Maxwell S.L. Quantitative aspiration during sleep in normal subjects. Chest 1997; 111: 1266-72.

16. Bartlett J.G. Anaerobic bacterial infections of the lung and pleural space. Clin. Infect. Dis. 1993; 16 (suppl. 4): S248-55.

17. Cassire H.A., Niederman M.S. Aspiration pneumonia, lipoid pneumonia, and lung abscess. In: Baum G.L., Crapo J.D., Celli B.R., Karlinsky J.B. (eds.). New York: Lippincot-Raven; 1998. 645-655.

18. Teabeaut J.R. Aspiration of gastric contents: An experimental study. Am. J. Pathol. 1952; 28: 51-67.

19. Moran T.J. Experimental aspiration pneumonia: inflammatory and reparative changes produced by intratracheal injections of autologous gastric juice and hydrochloric acid. Arch. Pathol. 1955; 60: 122-129.

20. Marom E.M., McAdams H.P., Erasmus J.J. The many faces of pulmonary aspiration. Am. J. Roentgenol. 1999; 172: 121-128.

21. Matsuse T., Oka T., Kida K., Fukuchi Y. Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest 1996; 110: 1289-1293.

22. Franquet T., Gimenez A., Rosуn N. et al. Aspiration diseases: findings, pitfalls, and differential diagnosis. Radiographics 2000; 20: 673-685.

23. Friedlander L., Fessler M.B. A 70-year-old man with migratory pulmonary infiltrates. Chest 2006; 130: 1269-1274.

24. Sadoun D., Valeyre D., Cargill J. et al. Bronchiolite oblitérante avec pneumonie en voie d'organisation en apparence cryptogénétique: mise en évidence d'un reflux gastro-oesophagien dans 5 cas. Presse Med. 1988; 17: 2383-2385.

25. Fleming C.M., Shepard J.A.O., Mark E.J. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2003. A 47-year-old man with waxing and waning pulmonary nodules five years after treatment for testicular seminoma. N. Engl. J. Med. 2003; 348: 2019-2027.

26. Cook D.J., Kollef M.H. Risk factors for ICU-acquired pneumonia. J. A. M. A. 1998; 279: 1605-1606.

27. Marquette C. Airway foreign bodies in adults. UpToDate. Last literature review for version 16.1: 2008.

28. Prass K., Braun J.S., Dirnagl U. et al. Stroke propogates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006; 37: 2607-2612.

29. Marik P.E., Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 2003; 124: 328-336.

30. Adnet F., Baud F. Relation between Glasgow Coma Scale and aspiration pneumonia. Lancet 1996; 348: 123-124.

31. deBoisblanc B.P. Body position and pneumonia. Crit. Care Med. 1999; 27: 678-679.

32. Kollef M.H. Ventilator-associated pneumonia: A multivariate analysis. J. A. M. A. 1993; 270: 1965-1970.

33. Adnet F., Borron S.W., Finot M.A. et al. Relation of body position at the time of discovery with suspected aspiration pneumonia in poisoned comatose patients. Crit. Care Med. 1999; 27: 745-748.

34. Martin B.J., Corlew M.M. The association of swallowing dysfunction and aspiration pneumonia. Dysphagia 1994; 9: 1-6.

35. Croghan J.E., Burke E.M., Caplan S. et al. Pilot study of 12-month outcomes of nursing home patients with aspiration on videofluoroscopy. Dysphagia 1994; 9: 141-146.

36. Langmore S.E., Terpenning M.S., Schork A. et al. Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia 1998; 13: 69-81.

37. Iverson L.I.G., May I.A., Samson P.C. Pulmonary complications in benign esophageal disease. Am. J. Surg. 1973; 126: 223-228.

38. McArthur M.S. Pulmonary complications of benign esophageal diseases. Am. J. Surg. 1986; 151: 296-299.

39. Marumo K., Homma S., Fukuchi Y. Postgastrectomy aspiration pneumonia. Chest 1995; 107: 453-456.

40. Dotson R.G., Robinson R.G., Pingleton S.K. Gastroesophageal reflux with nasogastric tubes: effect of nasogastric tube size. Am. J. Respir. Crit. Care Med. 1994; 149: 1659-1662.

41. Jones B., Ravich W.J., Donner M.W., Kramer S.S. Pharyngo-esophageal interrelationships: observations and working concepts. Gastroenterol. Radiol. 1985; 10: 225-233.

42. Sivit C.J., Curtis D.J., Crain M. et al. Pharyngeal swallow in gastroesophageal reflux disease. Dysphagia 1988; 2: 151-155.

43. Cook D.J., Reeve B.K., Guyatt G.H. et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. J. A. M. A. 1996; 275: 308-314.

44. Finucane T.E., Christmas C., Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. J. A. M. A. 1999; 282: 1365-1370.

45. Metheny N.A., Clouse R.E., Chang Y.H. et al. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes and risk factors. Crit. Care Med. 2006; 34: 1007-1015.

46. Metheny N.A. Strategies to prevent aspiration-related pneumonia in tube-fed patients. Respir. Care Clin. 2006; 12: 603-617.

47. Ibanez J., Penafiel A., Raurich J.M. et al. Gastroesophageal reflux in intubated patients receiving enteral nutrition: effect of supine and semirecumbent positions. J. Parenter. Enteral. Nutr. 1992; 16: 419-422.

48. Elpern E.H., Scott M.G., Petro L. et al. Pulmonary aspiration in mechanically ventilated patients with tracheostomies. Chest 1994; 105: 563-566.

49. Rello J., Sonora R., Jubert P. et al. Pneumonia in intubated patients: role of respiratory airway care. Am. J. Respir. Crit. Care Med. 1996; 154: 111-115.

50. Stewart S.L., Secrest J.A., Norwood B.R. et al. A comparison of endotracheal tube cuff pressures using estimation techniques and direct intracuff measurement. AANA J.; 2003; 71: 443-447.

51. Keller C., Brimacombe J., Bittersohl J. et al. Aspiration and the laryngeal mask airway: three cases and a review of the literature. Brit. J. Anaesth. 2004; 93: 579-582.

52. Sreebny L.M., Valdini A. Xerostomia: a neglected symptom. Arch. Intern. Med. 1987; 147: 1333-1337.

53. Terpenning M., Bretz W., Lopatin D. et al. Bacterial colonization of saliva and plaque in the elderly. Clin. Inf. Dis. 1993; 16: S314-S316.

54. Guggenheimer J., Moore P.A. Xerostomia: etiology, recognition and treatment. J. Am. Dent. Assoc. 2003; 134: 61-69.

55. Finegold S.M. Host factors predisposing to anaerobic infections. FEMS Immunol. Med. Microbiol. 1993; 6: 159-163.

56. Fernandez-Sola J., Junque A., Estruch R. et al. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch. Intern. Med. 1995; 155: 1649-1654.

57. Kidd D., Lawson J., Nesbitt R. et al. Aspiration in acute stroke: A clinical study with videofluoroscopy. Q. J. Med. 1993; 86: 825-829.

58. Marrie T.J., Durant H., Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev. Infect. Dis. 1989; 11: 586-599.

59. Torres A., Serra-Batlles J., Ferrer A. et al. Severe community-acquired pneumonia: etiology, epidemiology and prognostic factors. Am. Rev. Respir. Dis. 1991; 144: 312-318.

60. Moine P., Vercken J.P., Chevret S. et al. Severe community-acquired pneumonia: etiology, epidemiology and prognostic factors. Chest 1994; 105: 1487-1495.

61. Shigemitsu H., Afshar K. Aspiration pneumonias: under-diagnosed and under-treated. Curr. Opin. Pulm. Med. 2007; 13: 192-198.

62. Shariatzadeh M.R., Huang J.Q., Marrie T.J. Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility. J. Am. Geriatr. Soc. 2006; 54: 296-302.

63. Leroy O., Vandenbussche C., Coffinier C. et al. Community-acquired aspiration pneumonia in intensive care units. Epidemiological and prognosis data. Am. J. Respir. Crit. Care Med. 1997; 156: 1922-1929.

64. El-Solh A., Celestino P., Bhat A. et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am. J. Respir. Crit. Care Med. 2003; 167: 1650-1654.

65. Kozlow J.H., Berenholtz S.M., Garrett E. et al. Epidemiology and impact of aspiration pneumonia in patients undergoing surgery in Maryland, 1999-2000. Crit. Care Med. 2003; 31: 1930-1937.

66. Pennza P.T. Aspiration pneumonia, necrotizing pneumonia, and lung abscess. Emerg. Med. Clin. North Am. 1989; 7: 279-307.

67. Sa-Borges M., Rello J. Aspiration pneumonia. In: Marrie T.J., ed. Community aquered pneumonia. New York: Kluwer Academic / Plenum Publishers; 2001. 239-255.

68. Der Sahakian G., Perruche F., Dabreteau A. et al. Aspiration pneumonitis and Newton's law of gravitation. Am. J. Emerg. Med. 2007; 25: 987.e1-987.e2.

69. Bartlett J.G. Anaerobic bacterial pneumonitis. Am. Rev. Respir. Dis. 1979; 119: 19-23.

70. Finegold S.M. Aspiration pneumonia. Rev. Infect. Dis. 1991; 13 (suppl. 9): S737-S742.

71. Sosenko A., Glassroth J. Fiberoptic bronchoscopy in the evaluation of lung abscess. Chest 1985; 87: 489-494.

72. Stewart C.E., Winer-Muram H.T., Jennings S.G. et al. Necrotic mass-like upper lobe opacity. Chest 2003; 123: 277-279.

73. Allewelt M., Schuler P., Bolcskei P.L. et al. Ampicillin + sulbactam vs. clindamycin ± cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin. Microbiol. Infect. 2004; 10: 163-170.

74. Hirshberg B., Sklair-Levi M., Nir-Paz R. et al. Factors predicting mortality of patients with lung abscess. Chest 1999; 115: 746-750.

75. Bartlett J., Gorbach S., Tally F., Finegold S. Bacteriology and treatment of primary lung abscess. Am. Rev. Respir. Dis. 1974; 109: 510-517.

76. Cesar L., Gonzalez C., Calia F.M. Bacteriologic flora of aspiration-induced pulmonary infections. Arch. Intern. Med. 1975; 135: 711-714.

77. Hammond J.M.J., Potgieter P.D., Hanslo D. et al. The etiology and antimicrobial susceptibility patterns of microorganisms in acute community-acquired lung abscess. Chest 1995; 108: 937-941.

78. Lorber B., Swenson R.M. Bacteriology of aspiration pneumonia. Ann. Intern. Med. 1974; 81: 329-331.

79. Shah H.N., Collins M.D. Proposal for reclassification of Bacteroides asaccharolyticus, Bacteroides gingivalis, and Bacteroides endodontalis in a new genus, Porphyromonas. Int. J. Syst. Bacteriol. 1988; 38: 128-131.

80. Shah H.N., Collins M.D. Prevotella, a new genus to include Bacteroides melaninogenicus and related species formerly classified in the genus Bacteroides. Int. J. Syst. Bacteriol. 1990; 40: 205-208.

81. De A., Varaiya A., Mathur M. Anaerobes in pleuropulmonary infections. Ind. J. Clin. Microbiol. 2002; 20: 150-152.

82. Bartlett J.G. The Role of Anaerobic Bacteria in Lung Abscess. Clin. Infect. Dis. 2005; 40: 923-925.

83. Dore P., Robert R., Grollier G. et al. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am. J. Respir. Crit. Care Med. 1996; 153: 1292-1298.

84. Verma P. Laboratory diagnosis of anaerobic pleuropulmonary infections. Semin. Respir. Infect. 2000; 15: 114-118.

85. Marina M., Strong C.A., Civen R. et al. Bacteriology of anaerobic pleuropulmonary infections: preliminary report. Clin. Infect. Dis. 1993; 16 (suppl. 4): S256-S262.

86. Wimberley N., Faling J., Barlett J.G. A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. Am. Rev. Respir. Dis. 1979; 119: 337-343.

87. Chastre J., Viau F., Brun P. et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am. Rev. Respir. Dis. 1984; 130: 924-929.

88. Henriquez A.H., Mendoza J., Gonzalez P.C. Quantitative culture of bronchoalveolar lavage from patients with anaerobic lung abscesses. J. Infect. Dis. 1991; 164: 414-417.

89. Pena-Grinan N., Munoz-Lucena F., Vargas-Romero J. et al. Yield of percutaneous needle lung aspiration in lung abscess. Chest 1990; 97: 69-74.

90. Yang P.C., Luh K.T., Lee Y.C. et al. Lung abscesses: ultrasound (US) examination and US-guided transthoracic aspiration. Radiology 1991; 180: 171-175.

91. Wang J.-L., Chen K.-Y., Fang C.-T. et al. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin. Infect. Dis. 2005; 40: 915-922.

92. Robert R., Grollier G., Hira M., Dore P. A role for anaerobic bacteria in patients with ventilatory acquired pneumonia: yes or no? Chest 2000; 117: 1214-1215.

93. Mier L., Dreyfuss D., Darchy B. et al. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures. Intensive Care Med. 1993; 19: 279-284.

94. Marik P.E., Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest 1999; 115: 178-183.

95. Atherton S.T., White D.J. Stomach as a source of bacteria colonizing respiratory tract during artificial ventilation. Lancet 1978; 2: 968-969.

96. Rouby J.J., Laurent P., Gosnach M. et al. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am. J. Respir. Crit. Care Med. 1994; 150: 776-783.

97. Muder R.R. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am. J. Med. 1998; 105: 319-330.

98. Vergis E.N., Brennen C., Wagener M., Muder R.R. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch. Intern. Med. 2001; 161: 2378-2381.

99. Bartlett J.G. Bacteriology of hospital-acquired pneumonia. Arch. Intern. Med. 1986; 146: 868-871.

100. Robert R., Grollier G., Dore P. et al. Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome. J. Crit. Care 1999; 14: 114-119.

101. Grollier G., Dore P., Robert R. et al. Antibody response to Prevotella spp. in patients with ventilator-associated pneumonia. Clin. Diagn. Lab. Immunol. 1996; 3: 61-65.

102. Robert R., Nanadoumgar H., Grollier G. et al. Protected telescopic catheter also allows anaerobic bacteria isolation in patients with ventilatory-acquired pneumonia. Intensive Care Med. 2006; 32: 322-324.

103. Brun-Buisson C., Sollet J.P., Schweich H. et al. Treatment of ventilator-associated pneumonia with piperacillin-tazobactam / amikacin versus ceftazidime / amikacin: a multicenter, randomized controlled trial. VAP Study Group. Clin. Infect. Dis. 1998; 26: 346-354.

104. Bartlett J.G., Gorbach S.L. Treatment of aspiration pneumonia and primary lung abscess. Penicillin G vs clindamycin. J. A. M. A. 1975; 234: 935-937.

105. Lynch III J.P.. Bacterial pneumonia. In: Khan M.G., Lynch III J.P. (eds.). Pulmonary disease diagnosis and therapy. A practical approach. Baltimore: Williams & Wilkins; 1997. 297-374.

106. Галкин Д.В., Кречикова О.И., Сухорукова М.В., Дехнич А.В. Современные возможности терапии анаэробных инфекций. Клин. микробиол. и антимикроб. химиотер. 2006; 8: 298-313.

107. Eykyn S.J. Therapeutic use of metronidazole in aerobic infections: six years' experience in a London hospital. Surgery 1983; 141: 1424-1427.

108. Bartlett J.G. Treatment of anaerobic pulmonary infections. J. Antimicrob. Chemother. 1989; 24: 836-840.

109. Sanders C.V., Hanna B.J., Lewis A.C. Metronidazole in the treatment of anaerobic infections. Am. Rev. Respir. Dis. 1979; 120: 337-343.

110. Perlino C.A. Metronidazole vs clindamycin treatment of anaerobic pulmonary infections: failure of metronidazole therapy. Arch. Intern. Med. 1981; 141: 1427-1427.

111. The committee for The Japanese Respiratory Society guidelines in management of respiratory infections. Diagnosis, treatment, and prevention of aspiration pneumonia (excluding large-volume aspiration). Respirology 2006; 11 (suppl. 3): S117-S118.

112. Dubreuil L. Anaerobies stricts: bilan de sensibilite a l'associatuion amoxicilline-acide clavulanique. Etat de resistance aux antibiotiques. La Lettre de l'Infectiologue 1995; 13-19.

113. Germaud P., Poirier J., Jacqueme P. et al. Monotherapie par amoxicilline / acide clavulanique (AM-AC) en traitement de premiere intention dans les abces pulmonaires communautaires. A propos de 57 cas. Rev. Pneumol. Clin. 1993; 49: 137-141.

114. Fernandez-Sabe N., Carratala J., Dorca J. et al. Efficacy and safety of sequential amoxicillin/clavulanate in the treatment of anaerobic lung infections. Eur. J. Clin. Microbiol. Infect. Dis. 2003; 22: 185-187.

115. Marshall S.A., Aldridge K.E., Allen S.D. et al. Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5 000 recent clinical isolates from five medical centers. A reevaluation after five years. Diagn. Microbiol. Infect. Dis. 1995; 21: 153-168.

116. Munoz P., Garcia-Garrote F., Bouza E. Broad-spectrum b-lactam antibiotics with b-lactamase inhibitors. Int. J. Antimicrob. Agents 1996; 7 (suppl.): S9-S14.

117. Acuna C., Rabasseda X. Amoxicillin-sulbactam: A clinical and therapeutic review. Drugs Today 2001; 37: 193-210.

118. Perry C.M., Markham A. Piperacillin / tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs 1999; 57: 805-843.

119. Lee N.L.S., Yuen K.Y., Kumana C.R. B-lactam antibiotic and b-lactamase inhibitor combinations. J. A. M. A. 2001; 285: 386-388.

120. Williams J.D. Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone. Clin. Infect. Dis. 1997; 24: 494-497.

121. Levinson M., Mangura C., Lorber B. et al. Clindamycin compared with penicillin for the treatment of lung abscess. Ann. Intern. Med. 1983; 98: 466-471.

122. Gudiol F., Manresa F., Pallares R. et al. Clindamycin vs penicillin for anaerobic lung infections: high rate of penicillin failures associated with penicillin-resistant Bacteroides mela-ninogenicus. Arch. Intern. Med. 1990; 150: 2525-2529.

123. Kadowaki M., Demura Y., Mizuno S. et al. Reappraisal of clindamycin iv monotherapy for treaetment of mild-to-moderate aspiration pneumonia in elderly patients. Chest 2005; 127:1276-1282.

124. Pfaller M.A., Jones R.N. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30 254 aerobic and anaerobic pathogens isolated world wide. Diagn. Microbiol. Infect. Dis. 1997; 28: 157-163.

125. Grollier G. Sensibilite aux antibiotiques des anaerobies stricts en France: etude multicentrique. Path. Biol. 1994; 42: 498-504.

126. Wexler H.M., Molitoris D., Finegold S.M. In vitro activities of MK-826 (L-749, 345) against 363 strains of anaerobic bacteria. Antimicrob. Agents Chemother. 2000; 44: 2222-2224.

127. Livermore D.M., Carter M.W., Bagel S. et al. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob. Agents Chemother. 2001; 45: 1860-1867.

128. Fuchs P.C., Barry A.L., Brown S.D. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrob. Agents Chemother. 2001; 45: 1915-1918.

129. Kikuchi N., Onozaki I., Kohno N. et al. Clinical evaluation of therapy for aspiration pneumonia with imipenem / cilastatin sodium. Jpn. J. Antibiot. 1990; 43: 23-30.

130. Teng L.-J., Hsueh P.-R., Tsai J.-C. et al. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob. Agents Chemother. 2002; 46: 2908-2913.

131. Goldstein E.C., Citron D.M., Merriam C.V., Warren Y.A. Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents. Antimicrob. Agents Chemother. 2006; 50: 3507-3513.

132. Ackermann G., Schaumann R., Pless B. et al. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 2000; 19: 228-232.

133. Wexler H.M., Molitoris E., Molitoris D., Finegold S.M. In viro activity of moxifloxacin against anaerobic bacteria isolated from pulmonary specimens. Proceeding of ICAAC 1998: E211.

134. Nord C.E., Edlund C. Susceptibility of anaerobic bacteria to BAY 12-8039, a new methoxyquinolone. Proceeding of ECCMID 1997: P1157.

135. Polenakovik H., Burdette S.D., Polenakovik S. Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults. Infect. Dis. 2005; 41: 764-765.

136. Ott S.R., Allewelt M., Lorenz J. et al. Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection 2008; 36: 23-30.

137. Pujol M., Corbella X., Pena C. et al. Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 1998; 17: 622-628.

138. Peacock S.J., Garrard C.S. Ventilator-associated Pseudomonas aeruginosa pneumonia. Intensivmed. und Notfallmed. 1998; 35: 316-324.

139. Connors J.P., Roper C.L., Ferguson T.B. Transbronchial catheterization of pulmonary abscess. Ann. Thorac. Surg. 1975; 19: 254-260.

140. Rowe L.D., Keane W.M., Jafek B.W. et al. Transbronchial drainage of pulmonary abscesses with the flexible fiberoptic bronchoscope. Laryngoscope 1979; 89: 122-128.

141. Schmitt G.S., Ohar J.M., Kanter K.R. et al. Indwelling transbronchial catheter drainage of pulmonary abscess. Ann. Thorac. Surg. 1988; 45: 43-47.

142. Herth F., Ernst A., Becker H.D. Endoscopic drainage of lung abscesses: technique and outcome. Chest 2005; 127: 1378-1381.

143. Haggan J.L., Hardy J.D. Lung abscess revisited. A survey of 184 cases. Ann. Surg. 1983; 197: 755-761.

144. Potgieter P.D., Hammond J.M., Musson G., Odell J. Surgical drainage of lung abscess complicating acute community-acquired pneumonia. Chest 1991; 99: 1280-1282.

145. Yellin A., Yellin E.O., Lieberman Y. Percutaneous tube drainage: the treatment of choice for refractory lung abscess. Ann. Thorac. Surg. 1985; 39: 266-270.

146. VanSonnenberg E., D'Agostino H.B., Casola G. et al. Lung abscess: CT-guided drainage. Radiology 1991; 178: 347-351.

147. Wali S.O., Shugaeri A., Samman Y.S. et al. Percutaneous drainage of pyogenic lung abscess. Scand. J. Infect. Dis. 2002; 34: 673-679.

148. Cassina P.C., Hauser M., Hillejan L. et al. Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome. J. Thorac. Cardiovasc. Surg. 1999; 117: 234-238.

149. Villena V., Lopez-Encuentra A., Pozo F. et al. Measurement of pleural pressure during therapeutic thoracentesis. Am. J. Respir. Crit. Care Med. 2000; 162: 1534-8153.

150. Schiza S.E., Siafakas N.M. Clinical presentation and management of empyema, lung abscess and pleural effusion. Curr. Opin. Pulm. Med. 2006; 12: 205-211.


Для цитирования:


Авдеев С. Аспирационная пневмония: современные подходы к диагностике и терапии . Пульмонология. 2009;(2):5-19. https://doi.org/10.18093/0869-0189-2009-2-5-19

Просмотров: 104


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)